KRISTI ATKINS: Open Payments
NPI 1114427556 · RICHLAND, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 34 payments from 10 companies in 2025. Trend: 2023 $138 · 2024 $593 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $138 |
| Neurocrine BioSciences, Inc. | 4 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Alkermes, Inc. | 4 | $88 |
| Dexcom, Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Indivior Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, VIVITROL, Dexcom G6 Transmitter, MAVYRET, ABILIFY MAINTENA, Auvelity.
Industry payments across MO — which companies pay providers there.
